Showing results (91-100 of 152) with videos related to

Sort By:
Pageof 16
Nature Communications|November 29, 2024
Identification of HER2-positive breast cancer molecular subtypes with potential clinical implications in the ALTTO clinical trialMattia Rediti, David Venet, Andrea Joaquin Garcia, et al.
Frontiers in Immunology|August 27, 2021
COVID-19 Vaccination in Fragile Patients: Current Evidence and an Harmonized Transdisease TrialChiara Agrati, Serena Di Cosimo, Daniela Fenoglio, et al.
Frontiers in Oncology|November 7, 2022
Safety of third dose of COVID-19 vaccination in frail patients: Results from the prospective Italian VAX4FRAIL studySerena Di Cosimo, Maria Teresa Lupo-Stanghellini, Massimo Costantini, et al.
Breast Care (Basel, Switzerland)|February 20, 2018
Neoadjuvant Chemotherapy Exerts Selection Pressure Towards Luminal Phenotype Breast CancerGiulia Galli, Giacomo Bregni, Stefano Cavalieri, et al.
Frontiers in Oncology|February 17, 2023
End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTOSerena Di Cosimo, Chiara M Ciniselli, Sara Pizzamiglio, et al.
Cancers|December 1, 2020
Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib TrialElena López-Miranda, José Manuel Pérez-García, Serena Di Cosimo, et al.
Clinical Breast Cancer|August 29, 2024
Clinical and Biological Significance of HER2-Low in Ductal Carcinoma In Situ of the BreastChiara M Ciniselli, Paolo Verderio, Paolo Baili, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2005
Impact of five prophylactic filgrastim schedules on hematologic toxicity in early breast cancer patients treated with epirubicin and cyclophosphamidePaola Papaldo, Massimo Lopez, Paolo Marolla, et al.
Critical Reviews in Oncology/Hematology|October 25, 2024
The role of radiation therapy in the multidisciplinary management of male breast cancer: A systematic review and meta-analysis on behalf of the Clinical Oncology Breast Cancer Group (COBCG)Riccardo Ray Colciago, Valentina Lancellotta, Maria Carmen De Santis, et al.
Frontiers in Molecular Biosciences|October 13, 2022
Moving HER2-low breast cancer predictive and prognostic data from clinical trials into the real worldSerena Di Cosimo, Eliana La Rocca, Silva Ljevar, et al.
Pageof 16